Cancer

Description: This infographic highlights breast cancer statistics from the Canadian Cancer Registry (CCR). Breast cancer incidence is presented, as well as survival rates for women in Canada.

Description: Globally, cervical cancer is one of the most common cancers, yet it is largely preventable. Switching methods for primary screening from cytology testing, via Pap test, to human papillomavirus (HPV) testing is a component of that prevention. OncoSim-Cervix, a Canadian cervical cancer microsimulation model, assesses the long-term effects of HPV vaccination and screening interventions. This study projects the impact of differing roll-out strategies for HPV primary testing for cervical cancer screening in Canada.

Description: Release published in The Daily – Statistics Canada’s official release bulletin

Description: National estimates of five-year net survival for 57 types of cancer by age group at diagnosis. Net survival refers to the survival probability that would be observed in the hypothetical situation where the cancer of interest is the only possible cause of death.

Description: National estimates of five-year net survival for 12 types of cancer by age group at diagnosis. The age distributions of cases of these cancers are skewed toward older ages. Net survival refers to the survival probability that would be observed in the hypothetical situation where the cancer of interest is the only possible cause of death.

Description: Age-standardized national estimates of five-year net survival for 57 types of cancer. Net survival refers to the survival probability that would be observed in the hypothetical situation where the cancer of interest is the only possible cause of death.

Description: Age-standardized provincial estimates of five-year net survival for 11 types of cancer. Net survival refers to the survival probability that would be observed in the hypothetical situation where the cancer of interest is the only possible cause of death.

Description: National (excluding Quebec) estimates of five-year net survival for 31 types of cancer. Net survival refers to the survival probability that would be observed in the hypothetical situation where the cancer of interest is the only possible cause of death. Predicted survival provides a more up-to-date estimate of survival by exclusively using the survival experienced by cancer cases during a recent period.

Description: National (excluding Quebec) estimates of five-year net survival for 11 types of cancer by age group at diagnosis. Net survival refers to the survival probability that would be observed in the hypothetical situation where the cancer of interest is the only possible cause of death. Predicted survival provides a more up-to-date estimate of survival by exclusively using the survival experienced by cancer cases during a recent period.

Description: This fact sheet provides an overview of proportions of Canadians who have undergone tests commonly used for early detection of colorectal, cervical and breast cancer among people living in the ten provinces. It also examines differences by various groups, such as by sex, age, province, area type, racialized group, immigrant status, Indigenous group and disability status.

Description: National estimates of five-year net survival for 57 types of cancer by age group at diagnosis. Net survival refers to the survival probability that would be observed in the hypothetical situation where the cancer of interest is the only possible cause of death.

Description: National estimates of five-year net survival for 12 types of cancer by age group at diagnosis. The age distributions of cases of these cancers are skewed toward older ages. Net survival refers to the survival probability that would be observed in the hypothetical situation where the cancer of interest is the only possible cause of death.

Description: Age-standardized national estimates of five-year net survival for 57 types of cancer. Net survival refers to the survival probability that would be observed in the hypothetical situation where the cancer of interest is the only possible cause of death.

Description: Age-standardized provincial estimates of five-year net survival for 11 types of cancer. Net survival refers to the survival probability that would be observed in the hypothetical situation where the cancer of interest is the only possible cause of death.

Description: National (excluding Quebec) estimates of five-year net survival for 31 types of cancer. Net survival refers to the survival probability that would be observed in the hypothetical situation where the cancer of interest is the only possible cause of death. Predicted survival provides a more up-to-date estimate of survival by exclusively using the survival experienced by cancer cases during a recent period.

Description: National (excluding Quebec) estimates of five-year net survival for 11 types of cancer by age group at diagnosis. Net survival refers to the survival probability that would be observed in the hypothetical situation where the cancer of interest is the only possible cause of death. Predicted survival provides a more up-to-date estimate of survival by exclusively using the survival experienced by cancer cases during a recent period.

Description: Number of deaths caused by neoplasms, by age group and sex, 2000 to most recent year.

Description:

Number and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description:

The number of new cases, age-standardized rates and average age at diagnosis of cancers diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Cancer incidence rates are age-standardized using the direct method and the final 2011 Canadian postcensal population structure. Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description:

Annual percent change and average annual percent change in age-standardized cancer incidence rates since 1984 to the most recent diagnosis year. The table includes a selection of commonly diagnosed invasive cancers, as well as in situ bladder cancer. Cases are defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3) from 1992 to the most recent data year and on the International Classification of Diseases, ninth revision (ICD-9) from 1984 to 1991.

Description: This infographic highlights breast cancer statistics from the Canadian Cancer Registry (CCR). Breast cancer incidence is presented, as well as survival rates for women in Canada.

Description: Globally, cervical cancer is one of the most common cancers, yet it is largely preventable. Switching methods for primary screening from cytology testing, via Pap test, to human papillomavirus (HPV) testing is a component of that prevention. OncoSim-Cervix, a Canadian cervical cancer microsimulation model, assesses the long-term effects of HPV vaccination and screening interventions. This study projects the impact of differing roll-out strategies for HPV primary testing for cervical cancer screening in Canada.

Description: Release published in The Daily – Statistics Canada’s official release bulletin

Description: This fact sheet provides an overview of proportions of Canadians who have undergone tests commonly used for early detection of colorectal, cervical and breast cancer among people living in the ten provinces. It also examines differences by various groups, such as by sex, age, province, area type, racialized group, immigrant status, Indigenous group and disability status.

Description: The OncoSim-Breast model, developed by the Canadian Partnership Against Cancer and Statistics Canada, represents breast cancer-related events in the Canadian female population. This study aims to compare OncoSim-Breast microsimulation modelling results with recent results from the United States’ National Cancer Institute’s Cancer Intervention and Surveillance Modeling Network (CISNET) breast cancer models. The primary focus is on the impact of extending breast cancer screening to women aged 40 to 49.

Description: Managing breast cancer involves a range of health care settings and has considerable implications on health care resources. While studies have looked at breast cancer costs in Canada by subtype and stage, there is a gap in understanding breast cancer costs related to phase of care and disease stage. This study assessed health care system costs and resource utilization for adult women with breast cancer in Ontario, Canada. The goal was to update costs by stage, age, and phase of care from a health care system perspective.

Description: The validity of survival estimates from cancer registry data depends, in part, on the identification of the deaths of deceased cancer patients. People whose deaths are missed seemingly live on forever and are informally referred to as “immortals”, and their presence in registry data can result in inflated survival estimates. This study assesses the issue of immortals in the Canadian Cancer Registry (CCR) using a recently proposed method that compares the survival of long-term survivors of cancers for which “statistical” cure has been reported with that of similar people from the general population.

Description: According to recent Canadian estimates, over two in five Canadians will likely develop cancer in their lifetime, and one in four is expected to die of it. The lifetime probabilities of developing cancer and dying from cancer are useful summary statistics that describe the impact of cancer within a population. However, there is little information on how lifetime probabilities of developing cancer and dying from cancer have changed over time. This study aims to present detailed lifetime probabilities of developing cancer and dying from cancer by sex and cancer type, and to describe changes in these lifetime probabilities over time among the Canadian population.

Description: Cancer survival estimates provide insights into the effectiveness of early detection and treatment. The stage of cancer at diagnosis is an important determinant of survival, reflecting the extent and spread at the time of disease detection. The recent extension of the Canadian Cancer Registry death-linked analytic file from 2014 to 2017 now offers an opportunity to provide more up-to-date net survival (NS) figures and to profile, for the first time, five-year NS estimates for Canada (excluding Quebec). This study presents five-year stage-specific cancer and five-year NS estimates for the most commonly diagnosed cancers in Canada.

Description:

An evaluation of progress in cancer survival in Canada for all cancer types combined was recently conducted using the cancer survival index. This study provides a comprehensive evaluation of provincial-level progress in cancer survival for all cancer types combined in Canada.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The compendium of Canadian Cancer Registry procedures manuals set out the rules for reporting cancer data to the CCR for all provincial and territorial cancer registries.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The user guide to Death Clearance Feedback Reports is intended for users of the feedback reports. The feedback reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The Death Clearance Overview document describes the Death Clearance module of the Canadian Cancer Registry, its structure, its function and its role in the operation of the national cancer registry. Inputs and outputs are listed and briefly described, as well as the different steps constituting the Death Clearance process.

Description:

The Guidelines for Abstracting and Determining Death Certificate Only Cases are intended for use by all provincial and territorial cancer registries during their Death Clearance Process. The guidelines should be used when performing a comparison between the Death Certificate Notification and the cancer registry database.

Description:

This document examines the functional limitations - physical, emotional and social -experienced by patients at the time of diagnosis of cancer and as they undergo various treatments, remission, and palliative and terminal care. These functional limitations are described and classified using the Classification and Measurement System of Functional Health (CLAMES).

These descriptions and classifications are the first step in a new approach to measuring the health of Canadians that examines what factors are adversely affecting population health and how to address them. This document also provides health professionals, advocacy groups, and individual Canadians with an overview of how living with cancer affects day-to-day functioning.